- ... Fowler B, Yue WW, Baumgartner MR. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. ...
- ... Visser G. Fatty acid oxidation flux predicts the clinical severity of VLCAD ... and outcome of patients diagnosed through newborn screening in Victoria. ...
- ... Viau K, Botto LD, Pasquali M, Longo N. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2020;129:13- ...
- ... LD, Pasquali M, Longo N. Diagnosis, treatment, and clinical outcome of patients with mitochondrial trifunctional protein/long-chain 3-hydroxy acyl-CoA dehydrogenase deficiency. JIMD Rep. 2017; 31 :63–71. [ ...
- ... of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes. J Inherit Metab Dis. 2019;42:414-23. [ ...
- ... more is considered clinically important Global Function Summary outcome assessment of overall severity of condition Any improvement in global function is considered clinical improvement; however, results depend on an individual physician’ ...
- ... 1200/jop.19.00772. PMID: 32427537. - Addresses ONLY clinical trial recruitment outcome [ PMC free article : PMC7489480 ] [ PubMed : 32427537 ] [ CrossRef ] Hianik RS, Owonikoko T, Switchenko J, et al. Evaluating the impact of the Patient Preference Assessment Tool on clinicians’ recommendations for phase I oncology ...
- ... 1200/JCO.2001.19.13.3163. PMID: 11432882. Outcome [ PubMed : 11432882 ] [ CrossRef ] 1347. Merz EL, Tomfohr-Madsen L. Sleep Disruption in Pediatric Cancer Survivors: Conceptual Framework and Opportunities for Clinical Assessment and Behavioral Treatment. Am J Lifestyle Med. 2018 ...
- ... sample may not be representative of a larger clinical population Quality assessment: Overall rating: Poor Comments: - Unblinded - Randomization protocol poorly described - Small sample size - Poor reporting of outcomes by drug Applicability: - Inadequate description of patient population - ...
- ... CH) (DACH) recommendations have been used in several clinical trials and have resulted in ... of glutaryl-CoA. Combined metabolic therapy includes the following [ Boy et ...
88 results